MACQUARIE GROUP LTD

Position in AUPH — Aurinia Pharmaceuticals Inc.

CIK 1418333 Sydney, NSW 2000, C3

Position in AUPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$106,826

+$96,029 QoQ

Shares Held

6,295

+327.4% QoQ

Ownership

0.005%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#205

of 279 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. AUPH ranks #15 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	37,980	$18,865,804
2	REGN	Regeneron Pharmaceuticals, Inc.	17,532	$10,931,901
3	ALNY	Alnylam Pharmaceuticals, Inc.	20,943	$6,304,471
4	INCY	Incyte Corp	33,301	$3,775,000
5	RPRX	Royalty Pharma plc	41,037	$2,300,944
6	EXEL	Exelixis, Inc.	27,485	$1,495,458
7	RVMD	Revolution Medicines, Inc.	3,331	$623,829
8	INSM	INSMED Inc	5,193	$553,677

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$106,826	6,295	+327.4%	Shares	Sole	2026-08-14
2024-09-30	$10,797	1,473	-93.3%	Shares	Sole	2024-11-14
2024-06-30	$125,293	21,943	0.0%	Shares	Sole	2024-08-09
2024-03-31	$109,933	21,943	+1389.7%	Shares	Sole	2024-05-14
2023-12-31	$13,242	1,473	0.0%	Shares	Sole	2024-02-14
2023-09-30	$11,445	1,473	+322.1%	Shares	Sole	2023-11-14
2022-09-30	$2,624	349	-77.1%	Shares	Sole	2022-11-14
2022-03-31	$18,867	1,524	-71.8%	Shares	Defined	2022-05-16
2021-12-31	$123,680	5,408	+360.3%	Shares	Defined	2022-02-11
2021-09-30	$26,002	1,175	—	Shares	Defined	2021-11-12
No filing history on record for this holder in this stock.